参考文献/References:
[1] Gurvitz M,Dunn JE,Bhatt A,et al. Characteristics of adults with congenital heart defects in the United States[J]. J Am Coll Cardiol,2020,76(2):175-182.
[2] Gilboa SM,Devine OJ,Kucik JE,et al. Congenital heart defects in the United States:estimating the magnitude of the affected population in 2010[J]. Circulation,2016,134(2):101-109.
[3] Labombarda F,Hamilton R,Shohoudi A,et al. Increasing prevalence of atrial fibrillation and permanent atrial arrhythmias in congenital heart disease[J]. J Am Coll Cardiol,2017,70(7):857-865.
[4] Mandalenakis Z,Rosengren A,Lappas G,et al. Atrial fibrillation burden in young patients with congenital heart disease[J]. Circulation,2018,137(9):928-937.
[5] Kamp AN,Nair K,Fish FA,et al. Catheter ablation of atrial arrhythmias in patients post-Fontan[J]. Can J Cardiol,2022,38(7):1036-1047.
[6] Baumgartner H,de Backer J. The ESC clinical practice guidelines for the management of adult congenital heart disease 2020[J]. Eur Heart J,2020,41(43):4153-4154.
[7] Waldmann V,Khairy P. Pathophysiology,risk factors,and management of atrial fibrillation in adult congenital heart disease[J]. Card Electrophysiol Clin,2021,13(1):191-199.
[8] Waldmann V,Laredo M,Abadir S,et al. Atrial fibrillation in adults with congenital heart disease[J]. Int J Cardiol,2019,287:148-154.
[9] Gianni C,Mohanty S,Trivedi C,et al. Novel concepts and approaches in ablation of atrial fibrillation:the role of non-pulmonary vein triggers[J]. Europace,2018,20(10):1566-1576.
[10] Waldmann V,Guichard JB,Marijon E,et al. Tachyarrhythmias in congenital heart diseases:from ion channels to catheter ablation[J]. J Cardiovasc Dev Dis,2022,9(2):39.
[11] Gottlieb LA,Al Jefairi N,El Hamrani D,et al. Reduction in left atrial and pulmonary vein dimensions after ablation therapy is mediated by scar[J]. Int J Cardiol Heart Vasc,2021,37:100894.
[12] Escudero C,Khairy P,Sanatani S. Electrophysiologic considerations in congenital heart disease and their relationship to heart failure[J]. Can J Cardiol,2013,29(7):821-829.
[13] Giang KW,Fedchenko M,Dellborg M,et al. Burden of ischemic stroke in patients with congenital heart disease:a nationwide,case-control study[J]. J Am Heart Assoc,2021,10(13):e020939.
[14] Mandalenakis Z,Rosengren A,Lappas G,et al. Ischemic stroke in children and young adults with congenital heart disease[J]. J Am Heart Assoc,2016,5(2):e003071.
[15] Sinning C,Zengin E,Blankenberg S,et al. Anticoagulation management in adult patients with congenital heart disease:a narrative review[J]. Cardiovasc Diagn Ther,2021,11(6):1324-1333.
[16] Khairy P,Aboulhosn J,Broberg CS,et al. Thromboprophylaxis for atrial arrhythmias in congenital heart disease:a multicenter study [J]. Int J Cardiol,2016,223:729-735.
[17] Yang H,Bouma BJ,Mulder BJM,et al. Is initiating NOACs for atrial arrhythmias safe in adults with congenital heart disease?[J]. Cardiovasc Drugs Ther ,2017,31(4):413-417.
[18] Marelli A,Beauchesne L,Colman J,et al. Canadian Cardiovascular Society 2022 guidelines for cardiovascular interventions in adults with congenital heart disease[J]. Can J Cardiol,2022,38(7):862-896.
[19] Yang H,Bouma BJ,Dimopoulos K,et al. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention,are they safe in congenital heart disease? Results of a worldwide study[J]. Int J Cardiol,2020,299:123-130.
[20] Mongeon FP,Macle L,Beauchesne LM,et al. Non-vitamin K antagonist oral anticoagulants in adult congenital heart disease[J]. Can J Cardiol,2019,35(12):1686-1697.
[21] Wells R,Khairy P,Harris L,et al. Dofetilide for atrial arrhythmias in congenital heart disease:a multicenter study[J]. Pacing Clin Electrophysiol,2009,32(10):1313-1318.
[22] Miyazaki A,Ohuchi H,Kurosaki K,et al. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease[J]. Circ J,2008,72(12):1998-2003.
[23] Claeys MJ,Bondue A,Lancellotti P,et al. Summary of 2020 ESC guidelines on non-STE ACS,adult congenital heart disease,sports cardiology and atrial fibrillation[J]. Acta Cardiol,2022:77(10):864-872.
[24] Acena M,Anguera I,Dallaglio PD,et al. Atrial fibrillation ablation in adults with repaired congenital heart disease[J]. J Atr Fibrillation,2016,8(5):1363.
[25] Sohns C,Nürnberg JH,Hebe J,et al. Catheter ablation for atrial fibrillation in adults with congenital heart disease:lessons learned from more than 10 years following a sequential ablation approach[J]. JACC Clin Electrophysiol,2018,4(6):733-743.
[26] Philip F,Muhammad KI,Agarwal S,et al. Pulmonary vein isolation for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease[J]. Congenit Heart Dis,2012,7(4): 392-399.
[27] Liang JJ,Frankel DS,Parikh V,et al. Safety and outcomes of catheter ablation for atrial fibrillation in adults with congenital heart disease:a multicenter registry study [J]. Heart Rhythm,2019,16(6):846-852.
[28] Guarguagli S,Kempny A,Cazzoli I,et al. Efficacy of catheter ablation for atrial fibrillation in patients with congenital heart disease[J]. Europace,2019,21(9):1334-1344.
[29] Ebrahim MA,Escudero CA,Kantoch MJ,et al. Insights on atrial fibrillation in congenital heart disease[J]. Can J Cardiol,2018,34(11):1531-1533.
[30] Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS):the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC) Developed with the special contribution of the European Heart Rhythm Association(EHRA) of the ESC[J]. Eur Heart J,2021,42(5):373-498.
[31] Giamberti A,Pluchinotta FR,Chessa M,et al. Surgery for supraventricular tachycardia and congenital heart defects:long-term efficacy of the combined approach in adult patients[J]. Europace,2017,19(9):1542-1548.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(3):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(3):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(3):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(3):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(3):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]